Chimera Biotec

Chimera Biotec is a service provider for bioanalysis as well as development, validation and support of ultra-sensitive and technically demanding immunoassays. We provide ultra-sensitive GLP/GCP bioanalytical support for all phases of drug discovery and development. For over 20 years, we have specialized in supporting drug development programs with highest demands on bioanalytical quality. Our long standing expertise in beyond ELISA sensitive immunoassays enables us to make the most out of any immunoassay platform. Excellence in immunoassay development, validation and bioanalysis is our core motivation. Beginning with our proprietary Imperacer (Immuno-PCR) platform, which combines immunoassay specificity with an exponential real-time qPCR...

Ultra-sensitive lingand binding assay system: imperacer®,imperacer® assay development,imperacer® bioanalytical services,imperacer® instrumentation,ipcr,immunoassay,glp/gcp compliant,large-molecule sample testing support,limited or uncommon matrix testing,microsampling,simoa quanterix,high sensitivity elisa,immunoassay transfer,immunoassay validation,ultra-sensitive bioanalysis ,anysource® sample dilution,optimal bioanalytical data despite limited sample volume,pk support for biotherapeutics,biomarker support for biotherapeutics,and immunogenicity testing

Chimera biotec operates in the Biotechnology industry.

Chimera biotec's revenue is 11m - 100m

Chimera biotec has 11 - 50 employees.